Temporal partitioning of cardiac metabolism by the cardiomyocyte circadian clock
Abstract
New Findings
-
What is the topic of this review?
This review highlights temporal partitioning of cardiac metabolism by the cardiomyocyte circadian clock.
-
What advances does it highlight?
Advances include: 1) cardiac glucose utilization peaks during the active period to meet increased energetic demands at this time; 2) synthesis of glycogen and triglyceride peak in the heart during the latter half of the active period, likely in anticipation of the upcoming sleep/fasting period; and 3) protein turnover increases in the heart at the beginning of the sleep phase, probably to promote growth and repair at this time.
Cell-autonomous circadian clocks have emerged as crucial mediators of 24 h rhythms in cellular processes. In doing so, these molecular timekeepers confer the selective advantage of anticipation, allowing cells and organs to prepare for stimuli and stresses before their onset. The heart is subjected to dramatic fluctuations in energetic demand and nutrient supply in association with sleep–wake and fasting–feeding cycles. Recent studies suggest that the cardiomyocyte circadian clock orchestrates daily rhythms in both oxidative and non-oxidative glucose and fatty acid metabolism, as well as protein turnover. Here, I review this evidence and discuss whether disruption of these rhythms can contribute to cardiovascular disease.
Time-of-day-dependent rhythms are observed in multiple aspects of life, as well as death. In terms of cardiovascular parameters, blood pressure, heart rate and cardiac output all increase sharply at the beginning of the awake period, which is associated with increased risk of adverse ischaemic events, arrhythmias and sudden cardiac death at this time (reviewed by Durgan & Young, 2010). Classically, daily rhythms in cardiovascular physiology and pathophysiology have been attributed to fluctuations in neurohumoral factors and sheer stress associated with sleep–wake and fasting–feeding cycles (Young, 2006; Durgan & Young, 2010). Elegant studies by Scheer and colleagues have recently revealed that 24 h oscillations in multiple cardiovascular functions are intrinsically driven in healthy human subjects, thus highlighting a need to re-evaluate our understanding of the mechanisms modulating cardiovascular processes (Scheer et al. 1999, 2010). One intrinsic mechanism capable of driving 24 h rhythms in cellular processes is the circadian clock.
Circadian clocks are cell-autonomous mechanisms composed of transcriptional positive and negative feedback loops, with a free-running period of ∼24 h (reviewed by Takahashi et al. 2008). Clock components are expressed within individual cells in a ubiquitous manner and can operate in the absence of extrinsic cues. At the core of the mammalian mechanism are two transcription factors, CLOCK and BMAL1, which heterodimerize and bind to E-boxes in the promoters of target genes (Gekakis et al. 1998; Hogenesch et al. 1998). Target genes include repressors of CLOCK/BMAL1 (e.g. PER1/2/3, CRY1/2 and REV-ERBα), thus resulting in 24 h oscillations in the activity of this heterodimer (Takahashi et al. 2008). The CLOCK/BMAL1 heterodimer also modulates expression of non-core clock components, so-called clock output genes (CCGs). Translation of CCG mRNAs enables circadian clocks to influence cellular processes over the course of the day (Fig. 1). In general, circadian clocks confer a selective advantage by temporally partitioning cellular processes in anticipation of predicted daily fluctuations in the environment. Two major cycles that the heart must contend with on a daily basis are the sleep–wake and fasting–feeding cycles.
Following initial characterization of the cell-autonomous cardiomyocyte circadian clock (Durgan et al. 2005), two distinct mouse models were developed wherein this mechanism was genetically disrupted, namely cardiomyocyte-specific CLOCK mutant (CCM) and cardiomyocyte-specific BMAL1 knockout (CBK) mice (Durgan et al. 2006, 2011b; Bray et al. 2008; Young et al. 2014). Given the transcriptional nature of this mechanism, unbiased gene expression microarrays were performed initially, revealing that ∼10% of the cardiac transcriptome is regulated by the cardiomyocyte circadian clock (Bray et al. 2008; Young et al. 2014). Gene ontology analysis clustered CCGs into various categories, including transcription, signal transduction, transport and metabolism (Bray et al. 2008; Young et al. 2014). Potential clock control of metabolism was reinforced by an unbiased proteomics approach, indicating that ∼4% of the cardiac proteome is modulated by the cardiomyocyte circadian clock and that many of the identified proteins influence metabolic processes (Podobed et al. 2014). Collectively, these observations led to the hypothesis that the cardiomyocyte circadian clock allows the heart to predict/prepare for fluctuations in energetic demand and/or nutrient availability associated with sleep–wake and fasting–feeding cycles, through metabolic modulation.
During periods of physical activity (i.e. increased workload), the heart matches increased energetic demand primarily through stimulation of glucose utilization (Allard et al. 1994; Goodwin et al. 1998). Consistent with this knowledge, glucose oxidation is more than twofold higher in rodent hearts during the middle of the active (dark) phase [relative to the sleep (light) phase; Fig. 2; Young et al. 2001; Durgan et al. 2007, 2011a]. Evidence suggesting mediation by the cardiomyocyte circadian clock includes the following: (i) glucose oxidation rhythms are observed in ex vivo perfused hearts (in the absence of neurohumoral influence), even when cardiac work is constant (Durgan et al. 2011a); (ii) rhythms are absent in CCM hearts, which exhibit chronically low glucose oxidation rates (Durgan et al. 2011a); and (iii) peak glucose oxidation rates are markedly attenuated in CBK hearts (Young et al. 2014). In contrast, cardiac fatty acid oxidation rates do not exhibit a robust time-of-day-dependent oscillation, consistent with baseline requirements of this parameter independent of workload (although fatty acid oxidation is slightly higher at the sleep-to-wake transition; Fig. 2; Bray et al. 2008).
Unlike sleep–wake cycles, feeding–fasting cycles are less predictable for the animal in the wild, being dependent on successful foraging for food during the awake period. For the laboratory rodent fed ad libitum (mimicking a constant abundance of food, independent of time of day or season, much like humans in Westernized countries), one might predict increased nutrient storage during the awake/feeding period, in anticipation of an upcoming sleep/fasting period. Indeed, both glycogen and triglyceride synthesis oscillate in the ex vivo perfused mouse heart, peaking in the middle and at the end of the active (dark) phase (respectively; Fig. 2; Tsai et al. 2010; Durgan et al. 2011a). Importantly, these 24 h oscillations are absent in CCM hearts, indicative of mediation by the cardiomyocyte circadian clock (Tsai et al. 2010; Durgan et al. 2011a). Less is known regarding whether the cardiomyocyte circadian clock also anticipates unsuccessful foraging for food (i.e. prolongation of the sleep phase fast); in this situation, energetic demand of the heart will remain elevated during the continued search for food (and predation avoidance). Whether 24 h rhythms in glycogen and triglyceride turnover persist in the heart during prolonged fasting has not been addressed (although glycogen rhythms persist in the liver during fasting; Ishikawa & Shimazu, 1976).
Less is known regarding circadian influences on cardiac protein metabolism. Unpublished studies suggest that protein synthesis exhibits a 24 h oscillation in the murine heart, peaking at the beginning of the sleep (light) phase, with a prominent trough in the middle of the awake (dark) phase (Fig. 2). Circumstantial evidence suggests possible mediation by an intrinsic mechanism (e.g. the clock), because: (i) these rhythms persist ex vivo; (ii) pro-growth signals, such as sheer stress/workload, insulin and amino acids, all peak in the middle of the active (dark) phase, when cardiac protein synthesis troughs; and (iii) protein synthesis is altered (elevated) in CBK hearts (He et al. 2016b). These observations have led us to hypothesize that the cardiomyocyte circadian clock decreases protein synthesis during the active period to spare ATP for contraction, yet increases protein synthesis at the beginning of the sleep phase in an attempt to replace damaged proteins (in anticipation of the next awake period). If true, one would predict that the cardiomyocyte circadian clock would also promote protein degradation at the beginning of the sleep phase, thus facilitating replacement of damaged proteins. Consistent with this hypothesis, recent studies reveal that both autophagy (He et al. 2016a) and proteasome activity (J Zhang & ME Young, unpublished observations) are increased in the heart at the beginning of the sleep phase (Fig. 2).
Figure 2 summarizes evidence-based temporal partitioning of cardiac metabolic processes by the cardiomyocyte circadian clock. Major questions that can now be asked include the following. (i) How do intrinsic (i.e. cardiomyocyte circadian clock) and extrinsic influences (e.g. neurohumoral factors, such as insulin, β-adrenergic stimulation and various nutrients) co-ordinate cardiac metabolism in the in vivo setting? (ii) What are the molecular links between the cardiomyocyte circadian clock and metabolic processes? (iii) What, if any, are the pathological consequences of cardiomyocyte circadian clock control of cardiac metabolism? With regard to the last of these, evidence has emerged suggesting that the heart exhibits profound time-of-day-dependent oscillations in its responsiveness to pathological stresses, including ischaemia–reperfusion and pro-hypertrophic stimuli (Durgan et al. 2010, 2011b). Consistent with greater protein synthesis at the beginning of the sleep phase, challenging mice with isoprenaline at this time leads to greater hypertrophic growth of the heart (compared with isoprenaline challenge during the awake phase; Durgan et al. 2011b). Such observations may provide insight regarding the pathogenesis of hypertrophic cardiomyopathy associated with non-dipping hypertension and sleep apnoea, when the heart is challenged at an inappropriate time of day. Interestingly, ischaemia–reperfusion tolerance is highest in the heart at the beginning of the sleep phase (Durgan et al. 2010), a time when autophagy (a cardioprotective mechanism) is activated. It is tempting to speculate that disruption of the cardiomyocyte circadian clock by common behaviours such as sleep–wake disruption, shift work, frequent travel across time zones and nighttime eating significantly contributes towards cardiovascular disease risk through impairment of normal metabolic rhythms.
References
Additional information
Competing interests
None declared.
Funding
The work described here was supported by the National Heart, Lung, and Blood Institute (HL106199, HL074259, HL123574 and HL122975).
